USPTO Examiner WHALEY PABLO S - Art Unit 3619

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19195101SYSTEMS AND METHODS OF DIAGNOSING IDIOPATHIC PULMONARY FIBROSISApril 2025February 2026Abandon910NoNo
19026709TARGET RECOGNITION METHODS BASED ON ELECTROENCEPHALOGRAM SIGNALS IN NATURAL READING ENVIRONMENTJanuary 2025December 2025Abandon1120NoNo
18790796METHOD FOR CHARACTERIZING INTER-WELL CONNECTIVITY, DEVICE, MEDIUM AND PRODUCTJuly 2024January 2026Abandon1721NoNo
18710917DISEASE OR HEALTH CONDITION EXAMINATION METHOD AND EXAMINATION SYSTEMMay 2024January 2026Abandon2031YesNo
18591539SYSTEMS AND METHODS FOR TREATING, DIAGNOSING AND PREDICTING THE OCCURRENCE OF A MEDICAL CONDITIONFebruary 2024November 2025Abandon2010NoNo
18544115METHODS AND SYSTEMS FOR PERSONALIZED THERAPIESDecember 2023March 2025Abandon1511NoNo
18469522A METHOD AND SYSTEM FOR INSULIN MANAGEMENTSeptember 2023January 2025Allow1620YesYes
18357726METHOD AND SYSTEM OF CANCER DETECTION USING CPG-SNP CONTAMINATION MARKERSJuly 2023March 2026Allow3221YesYes
18324140A METHOD AND DOSING CONTROLLER FOR ADMINSTERING A CORRECTION DOSE OF INSULINMay 2023January 2026Allow3241NoNo
18311775METHODS AND SYSTEMS FOR LARGE SCALE SCAFFOLDING OF GENOME ASSEMBLIESMay 2023November 2025Abandon3011NoNo
18136098METHODS AND SYSTEMS FOR DETERMINING A PREGNANCY-RELATED STATE OF A SUBJECTApril 2023May 2024Abandon1310NoNo
18301891SYSTEMS AND METHODS FOR ASSESSING AND IMPROVING THE QUALITY OF MULTIPLEX MOLECULAR ASSAYSApril 2023January 2026Abandon3351NoNo
18189075CLASSIFICATION OF NUCLEIC ACID TEMPLATESMarch 2023March 2024Abandon1211YesNo
18165264DIRECT CLASSIFICATION OF RAW BIOMOLECULE MEASUREMENT DATAFebruary 2023October 2025Abandon3233YesNo
17818944METHOD FOR COMPARING DNA MOLECULESAugust 2022August 2023Abandon1242NoNo
17817581METHODS AND SYSTEMS FOR GENOMIC ANALYSISAugust 2022December 2024Abandon2850YesNo
17813440A METHOD AND SYSTEM FOR INSULIN BOLUS MANAGEMENTJuly 2022June 2023Allow1020NoNo
17703321CLASSIFIERS FOR DETECTION OF ENDOMETRIOSISMarch 2022July 2025Abandon4010NoNo
17592311METHODS AND SYSTEMS FOR DETERMINING A PREGNANCY-RELATED STATE OF A SUBJECTFebruary 2022January 2023Abandon1110NoNo
17624181GENOMIC AND EPIGENOMIC COMPARATIVE, INTEGRATIVE PATHWAY DISCOVERYDecember 2021February 2026Abandon4910NoNo
17560101METHOD OF NUCLEAR DNA AND MITOCHONDRIAL DNA ANALYSISDecember 2021June 2025Abandon4210NoNo
17542664A METHOD AND SYSTEM FOR IDENTIFYING POTENTIAL CONTAMINANTS IN TEST PLATESDecember 2021July 2023Allow1941YesNo
17608105INFORMATION PROVISION DEVICE AND METHOD FOR GENERATING MIRNA IMPORTANCE TABLENovember 2021March 2024Abandon2922YesNo
17604363PET FOOD RECOMMENDING DEVICE AND PET FOOD RECOMMENDING METHOD, SUPPLEMENT RECOMMENDING DEVICE AND SUPPLEMENT RECOMMENDING METHOD, AND INTESTINAL AGE CALCULATION FORMULA DETERMINING METHOD AND INTESTINAL AGE CALCULATION METHODOctober 2021November 2025Abandon4910NoNo
17474001SYSTEM AND METHOD FOR OPTIMIZING INSULIN DOSAGES FOR DIABETIC SUBJECTSSeptember 2021March 2023Allow1821NoYes
17404211METHODS AND APPARATUSES FOR USING ARTIFICIAL INTELLIGENCE TRAINED TO GENERATE CANDIDATE DRUG COMPOUNDS BASED ON DIALECTSAugust 2021March 2025Abandon4341NoYes
17396490SYSTEM FOR DETERMINING A HEALTH STATUS OF A TISSUE OF INTERESTAugust 2021March 2023Abandon2030YesNo
17396457SYSTEM FOR DETERMINING A HEALTH STATUS OF A TISSUE OF INTERESTAugust 2021December 2022Abandon1621NoNo
17429313METHOD AND APPARATUS FOR PREDICTING FLUID FLOW THROUGH A SUBJECT CONDUITAugust 2021November 2025Abandon5201NoNo
17305658A METHOD AND DOSING CONTROLLER FOR SUBCUTANEOUS OUTPATIENT MANAGEMENTJuly 2021February 2023Allow1930NoNo
17356868SYSTEMS AND METHODS OF ASSESSING SIGNIFICANCE OF METABOLITES IN DISEASESJune 2021May 2024Abandon3460NoNo
17339368METHOD FOR DETERMINING EFFICACY OF CHEMOTHERAPY TREATMENT FOR A SUBJECTJune 2021January 2026Allow5620NoNo
17286310SYSTEMS AND METHODS OF MANAGING DATA FOR GENOMIC SEQUENCINGApril 2021November 2024Abandon4360YesNo
17281716METHODS AND MATERIALS FOR DETECTING GENE COPY NUMBER VARIANTSMarch 2021March 2025Abandon4801NoNo
17200447METHOD FOR PERSONALIZED SELECTION OF A DRUG FOR A SUBJECTMarch 2021February 2025Abandon4710NoNo
17194823Biotechnology for curing hypothyroidismMarch 2021October 2024Abandon4421YesYes
17188546Method for Assessing Classification Annotations Assigned to DNA Sequences of OrganismsMarch 2021January 2023Abandon2331YesNo
17160191METHODS AND SYSTEMS FOR GENERATING A VIRTUAL PROGENY GENOMEJanuary 2021February 2025Abandon4810NoNo
17089234CLASSIFICATION OF TUMOR MICROENVIRONMENTSNovember 2020January 2026Abandon6051NoNo
17028713A METHOD AND SYSTEM FOR INSULIN INFUSION RATE MANAGEMENTSeptember 2020June 2023Allow3260NoNo
17013380METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITYSeptember 2020February 2022Abandon1720YesNo
16986042SYSTEM FOR DETERMINING A HEALTH STATUS OF A TISSUE OF INTERESTAugust 2020June 2022Abandon2241YesNo
16986057SYSTEM FOR DETERMINING A HEALTH STATUS OF A TISSUE OF INTERESTAugust 2020October 2023Abandon3961YesYes
16944048Method For Determining Genotypes in Regions of High HomologyJuly 2020August 2025Abandon6021NoNo
16934963Slope-Based CompensationJuly 2020May 2023Abandon3410NoNo
16930012SELF-DIRECTED METHOD FOR CELL-TYPE IDENTIFICATION AND SEPARATION OF GENE EXPRESSION MICROARRAYSJuly 2020December 2023Abandon4120NoNo
16889419Shear Force Generating Device for Analysis of Biopsied Mammalian SamplesJune 2020October 2025Abandon6031NoNo
16875645METHODS AND SYSTEMS FOR DETECTING RESIDUAL DISEASEMay 2020October 2024Abandon5341YesNo
16870703Biosensor Systems for Determining Analyte Concentration Based On Complex Index FunctionsMay 2020May 2024Abandon4801NoNo
16860792A METHOD OF DETECTING AND TREATING ENDOMETRIOSIS IN A FEMALE SUBJECTApril 2020December 2021Allow2021NoNo
16858463RESEARCH DATABASEApril 2020April 2024Abandon4811NoNo
16691480METHOD OF TREATING CANCERNovember 2019November 2020Allow1221YesNo
16689727PROCESS, COMPUTER-ACCESSIBLE MEDIUM AND SYSTEM FOR GENERATING A BIOLOGICAL MODEL ASSOCIATED WITH DISEASENovember 2019January 2024Abandon5010NoNo
16659544Hydration and Nutrition SystemOctober 2019December 2023Abandon4920NoNo
16656984GENE EXPRESSION PROFILES TO PREDICT BREAST CANCER OUTCOMESOctober 2019March 2023Abandon4110NoNo
16576643A METHOD FOR TREATING CANCERSeptember 2019August 2020Allow1121NoNo
16574056A METHOD AND SYSTEM FOR ADMINISTERING A CORRECTION BOLUS TO A PATIENTSeptember 2019August 2022Abandon3520YesYes
16561194METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR MAKING BASE CALLS IN NUCLEIC ACID SEQUENCINGSeptember 2019December 2024Abandon6021NoNo
16490084MONOMERIC BALANCE CONTROL IN THE PREPARATION OF PRECURSORS FOR POLYAMIDATION PROCESSESAugust 2019August 2025Abandon6041NoNo
16452406METHODS AND SYSTEMS FOR SEQUENCING-BASED VARIANT DETECTIONJune 2019January 2024Abandon5411NoNo
16449272A METHOD OF OPERATING A MEASUREMENT SYSTEM TO ANALYZE A POLYMERJune 2019October 2023Allow5261YesNo
16438757SYSTEMS AND METHODS FOR DETERMINING COPY NUMBER VARIATIONJune 2019June 2025Abandon6041NoNo
16406715SEQUENCE VARIANT ANALYSIS OF CELL-FREE DNA FOR CANCER SCREENINGMay 2019October 2025Abandon6041YesNo
16375237METHODS OF TREATING A SUBJECT WITH A HIGH GLEASON SCORE PROSTATE CANCERApril 2019February 2024Abandon5920NoNo
16361741NUCLEIC ACID SEQUENCING APPARATUS FOR MONITORING STATUS OF A TRANSPLANT RECIPIENTMarch 2019March 2021Allow2330YesNo
16353590GENE EXPRESSION PROFILES TO PREDICT BREAST CANCER OUTCOMESMarch 2019April 2022Abandon3710NoNo
16273316METHOD AND APPARATUS FOR ESTIMATING TEMPERATURE IN A BODYFebruary 2019February 2023Allow4820NoNo
16261037BIOMARKERS FOR TYPE 2 DIABETES MELLITUS AND USE THEREOFJanuary 2019December 2023Abandon5921YesNo
16244459APPARATUS AND METHOD FOR TRANSCRIPTOME ANALYSISJanuary 2019December 2023Abandon5930NoNo
16208149A METHOD FOR ADMINISTERING A CANCER TREATMENTDecember 2018May 2024Allow6060YesNo
16188882DYNAMIC PERSONALIZED CANCER TREATMENTNovember 2018October 2024Abandon6040NoNo
16099975ORTHOGONAL APPROACH TO INTEGRATE INDEPENDENT OMIC DATANovember 2018March 2025Abandon6031NoYes
16171596MACHINE LEARNING BASED ANTIBODY DESIGNOctober 2018November 2022Abandon4961YesNo
16093396USING THE FULL REPERTOIRE OF GENETIC INFORMATION FROM BACTERIAL GENOMES AND PLASMIDS FOR IMPROVED GENETIC RESISTANCE TESTSOctober 2018February 2024Abandon6021NoNo
16143708DETERMINATION OF JAK-STAT3 PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENESSeptember 2018June 2024Allow6031YesNo
16136533SYSTEMS, METHODS, AND PROCESSOR-READABLE MEDIA FOR DETECTING DISEASE CAUSAL VARIANTSSeptember 2018September 2022Abandon4801NoNo
16130886SYSTEMS AND METHODS FOR DE NOVO ASSEMBLY OF NUCLEOTIDE SEQUENCE READS USING A MODIFIED STRING GRAPHSeptember 2018September 2022Allow4811NoNo
16126879Method, System and Computer Program Product for Evaluation of Insulin Sensitivity, Insulin/Carbohydrate Ratio, and Insulin Correction Factors in Diabetes from Self-Monitoring DataSeptember 2018October 2025Abandon6060YesNo
16083492ALGORITHM AND AN IN VITRO METHOD BASED ON RNA EDITING TO SELECT PARTICULAR EFFECT INDUCED BY ACTIVE COMPOUNDSSeptember 2018December 2024Abandon6041YesNo
16109508A SYSTEM FOR ADMINISTERING INSULIN BOLUSES TO A PATIENTAugust 2018June 2020Allow2230NoYes
16064107DETECTION OF CHROMOSOME ABNORMALITIESJune 2018April 2025Abandon6041YesNo
16006129A METHOD FOR ADMINISTERING A CHECKPOINT BLOCKADE THERAPY TO A SUBJECTJune 2018June 2020Allow2421YesNo
15979374ADAPTIVE SIGNAL PROCESSING FOR INFUSION DEVICES AND RELATED METHODS AND SYSTEMSMay 2018October 2023Abandon6011NoNo
15969603SYSTEM FOR DETERMINING A HEALTH STATUS OF A TISSUE OF INTERESTMay 2018March 2021Abandon3450NoNo
15875197METHOD AND SYSTEM FOR DETERMINING INSULIN DOSING SCHEDULES AND CARBOHYDRATE-TO-INSULIN RATIOS IN DIABETIC PATIENTSJanuary 2018August 2022Abandon5511NoNo
15862819METHOD AND SYSTEM FOR OPTIMIZING INSULIN DOSAGES FOR DIABETIC SUBJECTSJanuary 2018December 2020Abandon3641NoYes
15820863SYSTEMS AND METHODS FOR TREATING, DIAGNOSING AND PREDICTING THE OCCURRENCE OF A MEDICAL CONDITIONNovember 2017March 2024Abandon6050NoNo
15794915EVALUATING AND CALLING SEQUENCESOctober 2017February 2022Abandon5101NoNo
15561025NORMALIZATION METHODS FOR MEASURING GENE COPY NUMBER AND EXPRESSIONSeptember 2017December 2021Abandon5001NoNo
15707818METHOD AND SYSTEM FOR SELECTING DRUG ON BASIS OF INDIVIDUAL PROTEIN DAMAGE INFORMATION FOR PREVENTING SIDE EFFECTS OF DRUGSeptember 2017October 2021Abandon4910NoNo
15686706SYSTEMS AND METHODS FOR TREATING, DIAGNOSING AND PREDICTING THE OCCURRENCE OF A MEDICAL CONDITIONAugust 2017October 2024Abandon6060NoNo
15667236SYSTEMS AND METHODS FOR NUCLEIC ACID-BASED IDENTIFICATIONAugust 2017October 2025Abandon6041NoYes
15667535A PATHWAY ANALYSIS COMPUTING SYSTEM AND METHODAugust 2017January 2021Allow4241YesNo
15667534A METHOD FOR TREATING AN INDIVIDUAL PATIENTAugust 2017September 2020Allow3741YesNo
15667544A PATIENT-SPECIFIC CELLULAR PATHWAY ACTIVITY INFERENCE COMPUTER SYSTEMAugust 2017November 2021Allow5261YesNo
15666174PROTEOGENOMIC ANALYSIS SYSTEM AND METHODSAugust 2017August 2021Abandon4901NoNo
15538821SYSTEMS, METHODS, AND APPARATUSES FOR SEQUENCE ALIGNMENTJune 2017March 2024Abandon6061NoNo
15616873Method And Computer System For Assessing Classification Annotations Assigned To DNA SequencesJune 2017July 2021Abandon5211NoNo
15496419A METHOD AND CONTROLLER FOR ADMINISTERING RECOMMENDED INSULIN DOSAGES TO A PATIENTApril 2017March 2021Allow4720NoNo
15487329METHOD AND SYSTEM OF ESTIMATING A SEQUENCE OF POLYMER UNITSApril 2017September 2024Allow60100YesYes

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WHALEY, PABLO S.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
18
Examiner Affirmed
16
(88.9%)
Examiner Reversed
2
(11.1%)
Reversal Percentile
24.1%
Lower than average

What This Means

With a 11.1% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
45
Allowed After Appeal Filing
9
(20.0%)
Not Allowed After Appeal Filing
36
(80.0%)
Filing Benefit Percentile
25.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner WHALEY, PABLO S - Prosecution Strategy Guide

Executive Summary

Examiner WHALEY, PABLO S works in Art Unit 3619 and has examined 155 patent applications in our dataset. With an allowance rate of 38.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 59 months.

Allowance Patterns

Examiner WHALEY, PABLO S's allowance rate of 38.1% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by WHALEY, PABLO S receive 4.14 office actions before reaching final disposition. This places the examiner in the 98% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by WHALEY, PABLO S is 59 months. This places the examiner in the 1% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +27.5% benefit to allowance rate for applications examined by WHALEY, PABLO S. This interview benefit is in the 75% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 8.0% of applications are subsequently allowed. This success rate is in the 3% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 15.6% of cases where such amendments are filed. This entry rate is in the 17% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 49% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 52.6% of appeals filed. This is in the 23% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 53.6% are granted (fully or in part). This grant rate is in the 54% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 5.8% of allowed cases (in the 87% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 35% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.